De Novo Biosimilar Monoclonal Antibodies Sequencing Service
Description
Creative Biolabs provides monoclonal antibodies sequencing service for biosimilar development, which provides full sequence coverage of the antibodies with 100% accuracy.Functional biosimilar monoclonal antibodies can be sequenced by subunit with 100% coverage as well as excellent precision based on our world's number one platform of de novo antibody sequencing using our proprietary Database Assisted Shotgun Sequencing (DASS) technology, all of which has been proved with abundant successful cases with 100% accuracy.